Our Story
Our Mission
Edaravone Injection
(10# NDC) 39822-4500-2
(11# NDC) 39822-4500-02
Disclaimer:
Product information on this website is intended for general information purposes only and is not a substitute for the approved product information. Buyers and consumers should not construe any information as medical advice or as a substitute for discussions with a qualified healthcare professional. XGen Pharmaceuticals DJB, Inc. and its affiliates accept no responsibility for the reliance on or use of any information contained herein.
30 mg/100 mL (0.3 mg/mL) x 2 Vials
For Intravenous Use Only
Description:
Edaravone injection is a clear, colorless liquid provided as a sterile solution.
30 mg/100 mL single-dose vials: Edaravone injection is supplied for intravenous infusion in a USP Type 1 Glass Vial containing 30 mg edaravone in 100 mL isotonic, sterile, aqueous solution. Individual vial will be placed in a carton (secondary packaging). Each single-dose vial contains the following inactive ingredients: L-cysteine hydrochloride hydrate (10 mg), sodium bisulfite (20 mg). Sodium chloride is added for isotonicity and phosphoric acid and sodium hydroxide are added to adjust to pH 4.
For more in-depth product and safety information, please review the full Prescribing Information or Packaging & Labeling links below.
Cencora 10294577
Cardinal 5952346
McKesson 2994812
Morris Dickson 437236
Store at controlled room temperature 25°C (77°F) [see USP]. Excursions permitted from 15°C to 30°C (59°F to 86°F)
[see USP Controlled Room Temperature].
Please see prescribing information for complete expiration date and storage requirements.
Latex Free
Protect from light
Edaravone Injection
(10# NDC) 39822-4510-1
(11# NDC) 39822-4510-01
Disclaimer:
Product information on this website is intended for general information purposes only and is not a substitute for the approved product information. Buyers and consumers should not construe any information as medical advice or as a substitute for discussions with a qualified healthcare professional. XGen Pharmaceuticals DJB, Inc. and its affiliates accept no responsibility for the reliance on or use of any information contained herein.
60 mg/100 mL (0.6 mg/mL) x 1 Vial
For Intravenous Use Only
Description:
Edaravone injection is a clear, colorless liquid provided as a sterile solution.
60 mg/100 mL single-dose vials: Edaravone injection is supplied for intravenous infusion in a USP Type 1 Glass Vial containing 60 mg edaravone in 100 mL isotonic, sterile, aqueous solution. Individual vial will be placed in a carton (secondary packaging). Each single-dose vial contains the following inactive ingredients: L-cysteine hydrochloride hydrate (20 mg), sodium bisulfite (40 mg). Sodium chloride is added for isotonicity and phosphoric acid and sodium hydroxide are added to adjust to pH 4.
For more in-depth product and safety information, please review the full Prescribing Information or Packaging & Labeling links below.
Cencora 10294630
Cardinal 5952353
McKesson 2994838
Morris Dickson 437087
Store at controlled room temperature 25°C (77°F) [see USP]. Excursions permitted from 15°C to 30°C (59°F to 86°F)
[see USP Controlled Room Temperature].
Please see prescribing information for complete expiration date and storage requirements.
Latex Free
Protect from light
Prescribing Information
Complaint or Adverse Event
Packaging & Labeling
XGEN PHARMACEUTICALS DJB, Inc. | 300 Daniel Zenker Drive | Horseheads NY, 14845
Our website uses session cookies.
View our Privacy Policy.